About HyperRho S/D Syringe
Rh(D) immune globulin
Used for
- Prevents Rh sensitization during pregnancy in Rh-negative people.
- Prevents Rh sensitization after exposure to Rh-positive blood, including transfusion.
Usual adult dose
Usually 300 micrograms (1,500 IU) intramuscularly at about 28 weeks’ pregnancy and within 72 hours after delivery if the newborn is Rh-positive.
Usual dose in children
Not routinely used in children; dosing after incompatible transfusion is based on the amount of Rh-positive blood exposure.
Common side effects
- Injection-site pain or tenderness
- Headache
- Mild fever or chills
- Allergic reactions, rarely severe
Important warnings
- Do not use in Rh-positive people or those previously sensitized to Rh(D).
- Rare severe allergic reactions can occur.
- May interfere with some blood tests and cause a positive direct antiglobulin test.
- Contains human plasma; residual risk of transmitting infections cannot be completely excluded.
Pregnancy
Used during pregnancy to prevent Rh sensitization; it does not treat established sensitization.
Breastfeeding
Compatible with breastfeeding; clinically significant transfer into breast milk is not expected.
Interactions
- May reduce responses to live vaccines, including measles, mumps, rubella, and varicella vaccines.
- Can interfere with blood typing and antiglobulin test results.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.